|
The makers of Restylane, Q-Med, are set to release Macrolane to UK consumers later this year.
The filler, based on hylauronic acid, like Restylane will evidently be targeted at women wanting breast enhancement without having implant surgery. The filler is injected into the breast via a catheter, and extensive clinical trials have been underway in Japan since last year.
The lead surgeon in UK tests will be Dr Chris Inglefield, who will give fellow surgeons an overview of the procedure at this week's Aesthetic Medicine conference in London.
The treatment though, does have its sceptics. Among them is a US surgeon, Dr Greg Buford from Denver. "Although its main focus has been treatment of soft tissue contouring irregularities following liposuction, some injectors have advocated its use as an alternative to implant breast augmentation." he says,
"Although I have an extensive background in the use of various HA fillers and feel them to be an excellent way in which to address volume loss, I do not see them as a cost-effective or long-term solution to breast implants. It would simply require too much volume to achieve desired results and the longevity of the product may require yearly touch-ups or more.
An announcement is expected from Q Med shortly.
|
back to main news 